University of Zurich
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Private
- Established
- 1833-04-29
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uzh.ch
THISTLE - The HIV-HCV Silibinin Trial
Phase 2
Completed
- Conditions
- Hepatitis CHIV
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 20
- Registration Number
- NCT01816490
- Locations
- π¨π
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study
- First Posted Date
- 2013-03-13
- Last Posted Date
- 2014-12-17
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 20
- Registration Number
- NCT01810549
- Locations
- π¨π
University Hospital Basel, Basel, Switzerland
Prospective, Randomized Clinical Trial Evaluating the ETView Double-Lumen Tube
Phase 4
Completed
- Conditions
- Patients Undergoing Elective Thoracic Surgery Requiring Obligatory Single-lung Ventilation During Surgery
- Interventions
- Device: ET View Double Lumen TubeDevice: conventional Double Lumen Tube
- First Posted Date
- 2013-03-08
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 40
- Registration Number
- NCT01807676
- Locations
- π¨π
University Hospital Zurich, Division of Anaesthesiology, Zurich, ZH, Switzerland
A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)
Phase 3
- Conditions
- Low Bone Mass in Anorexia Nervosa Patients
- Interventions
- Drug: osteoanabolic therapy
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 10
- Registration Number
- NCT01801397
- Locations
- π¨π
University Hospital Zurich, Rheumatology Department, Zurich, ZH, Switzerland
π¨πUniversity Hospital Zurich, Department of Psychiatry, Zurich, ZH, Switzerland
Randomized-controlled Trial (RCT) on CPAP-withdrawal and Microvascular Function in OSA
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnoea
- Interventions
- Other: CPAP therapy withdrawalProcedure: Continue CPAP treatment
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 45
- Registration Number
- NCT01797653
- Locations
- π¨π
University Hospital Zurich, Division of Pneumology, Zurich, ZH, Switzerland
The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Patients With Paroxysmal Atrial Fibrillation
- Interventions
- Other: Mueller manoeuvreOther: Inspiratory thresholdOther: Expiratory apnoeaOther: Steady state normal breathing
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 45
- Registration Number
- NCT01796080
- Locations
- π¨π
University Hospital Zurich, Division of Pneumology, Zurich, ZH, Switzerland
Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Drug: XOMA 052Drug: Placebo
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2014-02-11
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 22
- Registration Number
- NCT01788033
- Locations
- π¨π
University Hospital Basel, Basel, Switzerland
Skin Aging in Renal Transplant Patients
Completed
- Conditions
- Photosensitivity Disorders
- First Posted Date
- 2013-01-28
- Last Posted Date
- 2015-06-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 100
- Registration Number
- NCT01776983
- Locations
- π¨π
University Hospital Zurich, Department of Dermatology, Zurich, ZH, Switzerland
Adjuvant Effect of Chloroquine on Gemcitabine
- First Posted Date
- 2013-01-28
- Last Posted Date
- 2015-09-22
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 9
- Registration Number
- NCT01777477
- Locations
- π¨π
University Hospital Zurich, Department of Oncology, Zurich, ZH, Switzerland
Response of Hepatic Tumors to Radioembolization
Phase 2
Withdrawn
- Conditions
- Hepatocellular CarcinomaLiver MetastasisIntrahepatic Cholangiocarcinoma
- Interventions
- Radiation: Injection of Ytttrium-90 microspheres into the hepatic artery
- First Posted Date
- 2013-01-24
- Last Posted Date
- 2015-06-09
- Lead Sponsor
- University of Zurich
- Registration Number
- NCT01775280
- Locations
- π¨π
University Hospital Zurich, Divisions of Visceral Surgery and Nucelar Medicine, Zurich, ZH, Switzerland
Β© Copyright 2025. All Rights Reserved by MedPath